|Articles|April 14, 2019

Knowledge Gaps on Antibiotic Resistance Remain Among Health Care Workers in the EU

A large percentage (96%) of health care worker respondents reported feeling confident in their knowledge of antibiotic resistance, but only 60% answered the 7 key questions correctly.

Knowledge is the first step in combatting antibiotic resistance. Previous surveys have sought to identify the general public’s awareness on the subject, but there is no real body of evidence to illustrate the knowledge and attitudes of health care workers (HCW).

In a late-breaker poster at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019), investigators with Public Health England in London created a 43-question online survey with help from a project advisory group, which pilot-tested the questionnaire across Europe.

A total of 10,484 responses were collected from HCWs in 30 European Union (EU) and European Economic Area countries. Respondents worked in hospitals (54%), in the community (12%), in pharmacies (8%), in long-term care facilities (5%), in public health institutions (2%), in academic settings (2%), and in governmental organizations, industry, or professional settings (4%), and in other settings (13%).

A large percentage (96%) of questionnaire respondents reported feeling confident in their knowledge of antibiotic resistance, but only 60% answered the 7 key questions correctly.

For example, on a question about the use of antibiotics to promote growth of farm animals, only 29% of respondents knew the practice is illegal in the EU.

Eighty-eight percent of respondents acknowledged the connection between their antibiotic practices and the emergence or spread of antibiotic-resistant bacteria, while 57% agreed that they have a role in controlling antibiotic resistance. Medical doctors, in particular, acknowledged their role at a higher rate than any other HCW group (p<0.001).

“Less than half (42%) of respondents agreed that there was good promotion of prudent antibiotic use and antibiotic resistance prevention in their country, and only 28% believed that national campaigns were effective in reducing unnecessary antibiotic use,” investigators reported.

The survey, the first to include all of Europe, revealed that HCWs appear to have good awareness that their antibiotic practices have the potential to contribute to antibiotic resistance, but important knowledge gaps remain.

“There is also a need to empower HCWs as key players in controlling antibiotic resistance,” investigators concluded.

The study, “Healthcare workers' knowledge and attitudes about antibiotics and antibiotic resistance across 30 European Union and European Economic Area Countries,” was presented as a late-breaker poster on Saturday, April 13, 2019, at ECCMID 2019 in Amsterdam, the Netherlands.


Related to this article

This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.